The obesity paradox, which suggests a survival advantage for the obese in heart failure (HF)
has sparked debate in the medical community. Studies demonstrate a survival advantage in …

Obesity is a major public health challenge worldwide. It is costly, predisposes to many
cardiovascular (CV) diseases (CVD), is increasing at an alarming rate, and …

Interactions of hypertension, obesity, left ventricular hype... : Current Opinion in Cardiology
Interactions of hypertension, obesity, left ventricular hypertrophy, and heart failure : Current …

Background The role of metabolic and bariatric surgery (MBS), in synergy with left
ventricular assist device (LVAD) implantation, in the scope of end-stage heart failure …

Introduction Patients suffering from advanced heart failure may undergo left ventricular
assist device (LVAD) placement as a bridge to cardiac transplantation. However, those with …

For adults with advanced heart failure, class II/III obesity (body mass index≥ 35 kg/m2)
represents major challenges, and it is even considered a contraindication for heart …

Clinical considerations and pathophysiological associations... : Current Opinion in
Cardiology Clinical considerations and pathophysiological associations among obesity …

For adults with advanced heart failure, class II/III obesity (body mass index≥ 35 kg/m 2)
represents major challenges, and it is even considered a contraindication for heart …

The current study aims to evaluate the effect of bariatric metabolic surgery (BMS) on the New
York Heart Association (NYHA) class and left ventricular ejection fraction (LVEF) in patients …

Background The number of patients living with left ventricular assist devices (LVADs) has
gradually increased in the past decade. Non-cardiac surgery (NCS) in patients with LVAD …